antibiotic g 418 has been researched along with 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid in 1 studies
| Studies (antibiotic g 418) | Trials (antibiotic g 418) | Recent Studies (post-2010) (antibiotic g 418) | Studies (4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid) | Trials (4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid) | Recent Studies (post-2010) (4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid) |
|---|---|---|---|---|---|
| 515 | 0 | 102 | 21 | 5 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Light, Y; Marais, R; Martin, J; Spooner, RA; Springer, CJ | 1 |
1 other study(ies) available for antibiotic g 418 and 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid
| Article | Year |
|---|---|
Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Colonic Neoplasms; COS Cells; Drug Screening Assays, Antitumor; Female; gamma-Glutamyl Hydrolase; Genetic Therapy; Genetic Vectors; Gentamicins; Glutamates; Humans; Mutagenesis, Site-Directed; Nitrogen Mustard Compounds; Ovarian Neoplasms; Prodrugs; Transfection; Tumor Cells, Cultured | 1996 |